Eko Health worked closely with Mayo Clinic on low ejection fraction AI and worked with physicians to ensure the technology was applicable to a variety of patient populations.

“The ability to identify potentially life-threatening hidden cardiac conditions using a stethoscope, a familiar tool for primary care physicians and subspecialist clinicians, will help prevent hospitalizations and adverse events.” said Dr. Paul Friedman, director of the department. Mayo Clinic’s Division of Cardiovascular Medicine in Rochester, Minn., said in a statement announcing the news. “Importantly, because the stethoscope is small and portable, this technology can be used in urban and remote areas, and is expected to help address care in underserved areas. .”

“The stethoscope is one of the most recognizable symbols in healthcare, impacting an estimated one billion lives around the world each year,” added Connor Landgraf, co-founder and CEO of Eko Health. . “With Eko’s Low EF AI, we have turned a medical icon into an AI-powered early heart failure detection tool, saving millions of lives in a fraction of the time and cost of echocardiography. We are honored to collaborate with Mayo Clinic on this groundbreaking initiative. ”